New pill hopes to shrink Hard-to-Treat cancers
Disease control
Recruiting now
This early-phase study tests an experimental pill called BB102 in people with advanced solid tumors that have not responded to standard treatments. The drug targets a protein (FGFR4) that may help some cancers grow. The main goals are to check safety, find the best dose, and see …
Phase: PHASE1 • Sponsor: Broadenbio Ltd., Co. • Aim: Disease control
Last updated May 02, 2026 07:54 UTC